Celanese Corporation

LSE:0HUR Stock Report

Market Cap: US$4.6b

Celanese Valuation

Is 0HUR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0HUR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0HUR ($42.31) is trading below our estimate of fair value ($124.96)

Significantly Below Fair Value: 0HUR is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0HUR?

Key metric: As 0HUR is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0HUR. This is calculated by dividing 0HUR's market cap by their current revenue.
What is 0HUR's PS Ratio?
PS Ratio0.5x
SalesUS$9.71b
Market CapUS$4.62b

Price to Sales Ratio vs Peers

How does 0HUR's PS Ratio compare to its peers?

The above table shows the PS ratio for 0HUR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.6x
JMAT Johnson Matthey
0.3x-46.61%UK£3.7b
CRDA Croda International
2.3x4.95%UK£3.8b
ELM Elementis
1.7x-3.53%UK£946.8m
VCT Victrex
2x3.98%UK£574.4m
0HUR Celanese
0.5x1.24%US$4.6b

Price-To-Sales vs Peers: 0HUR is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (1.6x).

Price to Sales Ratio vs Industry

How does 0HUR's PS Ratio compare vs other companies in the GB Chemicals Industry?

4 CompaniesPrice / SalesEstimated GrowthMarket Cap
SYNT Synthomer
0.05x2.38%US$139.69m
HEIQ HeiQ
0.2xn/aUS$9.61m
BYOT Byotrol
0.1xn/aUS$569.29k
BIOM Biome Technologies
0.07x33.12%US$499.55k
No more companies available in this PS range
0HUR 0.5xIndustry Avg. 1.0xNo. of Companies4PS01.22.43.64.86+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 0HUR is good value based on its Price-To-Sales Ratio (0.5x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is 0HUR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0HUR PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.5x
Fair PS Ratio1.2x

Price-To-Sales vs Fair Ratio: 0HUR is good value based on its Price-To-Sales Ratio (0.5x) compared to the estimated Fair Price-To-Sales Ratio (1.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0HUR forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$42.31
US$51.31
+21.29%
27.47%US$100.00US$40.00n/a16
Dec ’26US$42.37
US$52.50
+23.91%
26.54%US$100.00US$40.00n/a16
Nov ’26US$38.60
US$53.69
+39.07%
27.52%US$100.00US$40.00n/a16
Oct ’26US$41.83
US$54.31
+29.84%
27.82%US$100.00US$40.00n/a16
Sep ’26US$47.47
US$54.94
+15.73%
27.09%US$100.00US$40.00n/a16
Aug ’26US$48.59
US$64.94
+33.65%
22.21%US$110.00US$47.00n/a16
Jul ’26US$58.59
US$62.54
+6.74%
24.59%US$110.00US$47.00n/a17
Jun ’26US$52.51
US$58.95
+12.26%
25.93%US$110.00US$45.00n/a18
May ’26US$44.83
US$58.01
+29.39%
29.75%US$120.00US$40.00n/a20
Apr ’26US$55.92
US$63.89
+14.26%
24.88%US$120.00US$46.00n/a19
Mar ’26US$51.00
US$65.50
+28.43%
25.27%US$120.00US$46.00n/a18
Feb ’26US$71.86
US$86.39
+20.23%
20.68%US$150.00US$70.00n/a18
Jan ’26US$68.96
US$93.00
+34.87%
19.11%US$150.00US$73.00US$42.2618
Dec ’25US$73.21
US$103.50
+41.37%
17.07%US$150.00US$76.00US$42.3718
Nov ’25US$125.24
US$146.26
+16.79%
10.83%US$178.00US$120.00US$38.6019
Oct ’25US$134.77
US$148.40
+10.11%
11.25%US$178.00US$120.00US$41.8320
Sep ’25US$128.83
US$151.40
+17.52%
10.96%US$180.00US$128.00US$47.4720
Aug ’25US$137.33
US$160.10
+16.58%
9.89%US$184.00US$130.00US$48.5920
Jul ’25US$132.24
US$164.00
+24.02%
9.88%US$193.00US$130.00US$58.5920
Jun ’25US$150.25
US$166.86
+11.06%
9.63%US$197.00US$140.00US$52.5121
May ’25US$153.59
US$162.23
+5.62%
9.86%US$199.00US$138.00US$44.8322
Apr ’25US$171.52
US$156.82
-8.57%
10.29%US$195.00US$120.00US$55.9222
Mar ’25US$153.11
US$156.14
+1.98%
9.46%US$180.00US$120.00US$51.0022
Feb ’25US$145.06
US$148.23
+2.18%
11.38%US$176.00US$120.00US$71.8622
Jan ’25US$156.57
US$140.29
-10.40%
10.78%US$169.00US$117.30US$68.9622
US$51.49
Fair Value
17.8% undervalued intrinsic discount
16
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/03 12:15
End of Day Share Price 2026/01/02 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Celanese Corporation is covered by 34 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
Ghansham PanjabiBaird
Sergey VasnetsovBarclays